Clinical Trial Update: NK Cell Infusions With Trastuzumab for Patients With HER2+ Breast and Gastric Cancer [Phase 1, Phase 2]

View source ↗

Summary

A clinical trial update evaluating NK cell infusions in combination with trastuzumab for HER2-positive breast and gastric cancer in Phase 1/Phase 2. The current…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Gastric Cancer

Drugs mentioned

• NK cell infusion
• Trastuzumab (trastuzumab)

Snippet

Sponsor: National University Hospital, Singapore | Conditions: Breast Cancer, Gastric Cancer | Phase 1, Phase 2 | Status: UNKNOWN